Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fanconi's anemia. Current concepts.

B P Alter1

  • 1Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029.

The American Journal of Pediatric Hematology/Oncology
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

VACTERL-H Association and Fanconi Anemia.

Molecular syndromology·2013
Same author

Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.

Bone marrow transplantation·2010
Same author

Oral and dental phenotype of dyskeratosis congenita.

Oral diseases·2008
Same author

Griscelli syndrome: rare neonatal syndrome of recurrent hemophagocytosis.

Journal of pediatric hematology/oncology·2002
Same author

Modern review of congenital hypoplastic anemia.

Journal of pediatric hematology/oncology·2001
Same author

Comparative genome analysis delimits a chromosomal domain and identifies key regulatory elements in the alpha globin cluster.

Human molecular genetics·2001
Same journal

Transient abnormal myelopoiesis in Down's syndrome neonates.

The American journal of pediatric hematology/oncology·1994
Same journal

Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins.

The American journal of pediatric hematology/oncology·1994
Same journal

Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma.

The American journal of pediatric hematology/oncology·1994
Same journal

Sphenoid sinus involvement in neuroblastoma.

The American journal of pediatric hematology/oncology·1994
Same journal

Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.

The American journal of pediatric hematology/oncology·1994
Same journal

Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome.

The American journal of pediatric hematology/oncology·1994
See all related articles

Fanconi's anemia is a genetic disorder often leading to aplastic anemia and increased cancer risk. Diagnosis involves checking for chromosomal breakage, and while transplants can cure, androgens are a common treatment.

Area of Science:

  • Hematology
  • Genetics
  • Oncology

Background:

  • Fanconi's anemia is an autosomal recessive disorder.
  • Characterized by high incidence of aplastic anemia (>90%) and a premalignant component with significant risk of leukemia or solid tumors (>10%).

Purpose of the Study:

  • To summarize the clinical presentation, diagnosis, and management of Fanconi's anemia.
  • To highlight the variability in prognosis and potential for new therapeutic approaches.

Main Methods:

  • Diagnosis relies on detecting increased chromosomal breakage in lymphocytes after exposure to DNA cross-linking agents.
  • Review of clinical outcomes, including pregnancy, bone marrow abnormalities, and response to treatment.

Main Results:

Related Experiment Videos

  • Patients can be clinically well with normal physical appearance despite the disorder.
  • Pregnancy is possible with minimal adverse effects on maternal hematologic status.
  • Clonal cytogenetic abnormalities may be present without immediate leukemic transformation.
  • In vitro erythropoiesis studies correlate with clinical status and suggest potential for growth factor therapies.

    • Conclusions:

    • Fanconi's anemia diagnosis is confirmed by specific laboratory tests.
    • Treatment options include bone marrow/cord blood transplants and androgen therapy.
    • Prognosis varies, with many adults living full lives, some with families.
    • Emerging therapies targeting erythropoiesis show promise.